Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Free White Paper

US Scientist Forms Changzhou Vaccine Company

publication date: Apr 25, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Changzhou Tongtai Biopharmaceutical Co., Ltd. is being launched with the goal of producing inactivated rabies animal vaccines. Presently, China veterinarians have to choose between a less-effective, domestically produced, attenuated rabies inactivated vaccine and a more expensive imported vaccine. Changzhou Tongtai expects to be the first company in China with a domestically produced inactivated rabies vaccine, offering safety and efficacy at a low cost. The effort is under the supervision of a team of overseas scientists, headed by Dr. Fu Zhenfang, Professor of Veterinary Pathology at the College of Veterinary Medicine, the University of Georgia. More details...




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

  

    
   
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events

China Healthcare Investment Conference 2012
March 13-15, 2012
Shanghai, China


Shanghai CEO Conference
March 28-29, 2012
Shanghai, China

>>More details...
Other Events

China Pharmaceutical R&D Summit
April 23-26, 2012
Shanghai, China


Biosimilars Asia 2012
April 23-26, 2012
Shanghai, China


Vaccines China 2012
April 23-26, 2012
Shanghai, China

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners